Generics
BI-LO announces prescription prices for generic form of PLAVIX
1 October 2012 - BI-LO, a subsidiary of BI-LO Holding, announced on September 28 that the generic form of PLAVIX(r) is available for USD4.00 for 30 day, and USD10.00 for 90-day prescriptions. The med...
Sanofi and Bristol-Myers Squibb awarded USD0.443m from Apotex in Plavix patent litigation
9 February 2012 - Healthcare company Sanofi (Euronext:SAN) (NYSE: SNY) and biopharmaceutical company Bristol-Myers Squibb Company (NYSE: BMY) announced yesterday that Apotex has made a payment of USD4...
Dr Reddy's Q3 2011/2012 EBITDA rises 127%
3 February 2012 - Indian pharmaceuticals maker Dr Reddy's Laboratories Ltd (BOM:500124; NYSE:RDY) today reported a 127% annual EBITDA growth to INR9.2bn (USD189m/EUR143m) for the third quarter of...
Glaxo, Lilly, Pfizer join race for MN Pharmaceuticals
1 February 2012 - Pharmaceutical giants GlaxoSmithKline Plc (LON:GSK), Eli Lilly & Co (NYSE:LLY) and Pfizer Inc (NYSE:PFE) are said to be in the race for a stake in Turkish generic drug maker Must...
Lannett gains FDA nod for supplemental ANDA for obesity management drug
1 February 2012 - US generic drugs maker Lannett Company Inc (NYSEAMEX:LCI) said on Tuesday it had obtained US Food and Drug Administration (FDA) approval for its supplemental Abbreviated New Drug App...
Stada wraps up purchase of Spirig's generics biz
31 January 2012 - German Stada Arzneimittel AG (ETR:SAZ) said on Tuesday it had finalised the acquisition of the generics business of Swiss Spirig Pharma for CHF97m (USD106.1m/EUR80.5m).The parties co...